IGF2BP3 Gene

HGNC Family	RNA binding motif containing (RBM)
Name	insulin-like growth factor 2 mRNA binding protein 3
Description	The protein encoded by this gene is primarily found in the nucleolus, where it can bind to the 5' UTR of the insulin-like growth factor II leader 3 mRNA and may repress translation of insulin-like growth factor II during late development. The encoded protein contains several KH domains, which are important in RNA binding and are known to be involved in RNA synthesis and metabolism. A pseudogene exists on chromosome 7, and there are putative pseudogenes on other chromosomes. [provided by RefSeq, Jul 2008]
Summary	{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n IGF2BP3 is an oncofetal RNA‐binding protein that plays a pivotal role in cancer by governing the post‐transcriptional fate of key mRNAs. Functioning as an m<sup>6</sup>A reader, IGF2BP3 modulates mRNA stability and translation of genes involved in cell cycle progression, angiogenesis, epithelial‐mesenchymal transition, and metastasis. Its overexpression has been documented in a variety of human tumors, including melanoma"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", pancreatic ductal adenocarcinoma"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ", and glioblastoma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In colon cancer, IGF2BP3 has been shown to bind mRNAs such as those for Cyclin D1 and VEGF—regulating their stability via m<sup>6</sup>A modifications—to promote S phase progression, cell proliferation, and angiogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In liver cancer models driven by Lin28B, IGF2BP3 is required to sustain tumor growth"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", while in laryngeal squamous cell carcinoma, m<sup>6</sup>A modifications mediated by RBM15 enhance the stability of TMBIM6 mRNA in an IGF2BP3‐dependent manner."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Noncoding RNAs further modulate its function; for example, in glioma, circNEIL3 stabilizes IGF2BP3 by protecting it from ubiquitination, thereby promoting tumor invasion and remodeling of the tumor microenvironment"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ", and in prostate cancer, a circular RNA enhances HDAC4 mRNA stability via binding to IGF2BP3, which in turn promotes epithelial–mesenchymal transition."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " In diagnostic settings, IGF2BP3 (often referred to as IMP3) has emerged as a sensitive biomarker in several cancers such as pancreatic"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "and ovarian clear cell carcinomas"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ", and its high expression is associated with chemoresistance and poor prognosis in ovarian"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "and bladder cancers, where it activates oncogenic signaling pathways like JAK/STAT."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " Moreover, in breast cancer cells, IGF2BP3 protects TRIM25 mRNA from miRNA-mediated degradation, underscoring its role in fostering cell proliferation"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": ", and in gastric cancer, its expression is negatively regulated by tumor-suppressive miR-34a."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " Collectively, these findings establish IGF2BP3 as a central post‐transcriptional regulator that enhances oncogenic signaling and tumor progression, highlighting its potential as both a prognostic biomarker and a therapeutic target."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "15"}, {"type": "fg_f", "ref": "8"}, {"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Douglas Hanniford, Alejandro Ulloa-Morales, Alcida Karz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccell.2019.12.007"}], "href": "https://doi.org/10.1016/j.ccell.2019.12.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31935372"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31935372"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sita Kugel, Carlos Sebastián, Julien Fitamant, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2016.04.033"}], "href": "https://doi.org/10.1016/j.cell.2016.04.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27180906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27180906"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Ramaswamy Suvasini, Bhargava Shruti, Balaram Thota, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.178012"}], "href": "https://doi.org/10.1074/jbc.M110.178012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21613208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21613208"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Zhou Yang, Tingfeng Wang, Dejun Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-020-01714-8"}], "href": "https://doi.org/10.1186/s13046-020-01714-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32993738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32993738"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Liem H Nguyen, Daisy A Robinton, Marc T Seligson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2014.06.018"}], "href": "https://doi.org/10.1016/j.ccr.2014.06.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25117712"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25117712"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xin Wang, Linli Tian, Yushan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-021-01871-4"}], "href": "https://doi.org/10.1186/s13046-021-01871-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33637103"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33637103"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ziwen Pan, Rongrong Zhao, Boyan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-021-01485-6"}], "href": "https://doi.org/10.1186/s12943-021-01485-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35031058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35031058"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yu-Zhong Yu, Dao-Jun Lv, Chong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-021-01480-x"}], "href": "https://doi.org/10.1186/s12943-021-01480-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34986849"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34986849"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Rhonda K Yantiss, Bruce A Woda, Gary R Fanger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.pas.0000149688.98333.54"}], "href": "https://doi.org/10.1097/01.pas.0000149688.98333.54"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15644775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15644775"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Martin Köbel, Haodong Xu, Patricia A Bourne, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2008.206"}], "href": "https://doi.org/10.1038/modpathol.2008.206"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19136932"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19136932"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "K-F Hsu, M-R Shen, Y-F Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2015.254"}], "href": "https://doi.org/10.1038/bjc.2015.254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26158423"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26158423"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Wei Huang, Yuanyuan Li, Cheng Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.16003"}], "href": "https://doi.org/10.1111/jcmm.16003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33094561"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33094561"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Zhenzhen Wang, Dongdong Tong, Cong Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2018.12.061"}], "href": "https://doi.org/10.1016/j.ebiom.2018.12.061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30797711"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30797711"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yuhang Zhou, Tingting Huang, Ho Lam Siu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-017-0647-2"}], "href": "https://doi.org/10.1186/s12943-017-0647-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28399871"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28399871"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Jayanth Kumar Palanichamy, Tiffany M Tran, Jonathan M Howard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI80046"}], "href": "https://doi.org/10.1172/JCI80046"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26974154"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26974154"}]}]}]}
Synonyms	IMP3, CT98, KOC1, VICKZ3, KOC, IMP-3
Proteins	IF2B3_HUMAN
NCBI Gene ID	10643
API
Download Associations
Predicted Functions
Co-expressed Genes
Expression in Tissues and Cell Lines

Functional Associations

IGF2BP3 has 14,935 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 125 datasets.

Click the + buttons to view associations for IGF2BP3 from the datasets below.

If available, associations are ranked by standardized value

Harmonizome 3.0

IGF2BP3 Gene

Functional Associations

Please acknowledge the Harmonizome in your publications by citing the following reference(s):

	Dataset	Summary
	Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of IGF2BP3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	tissues with high or low expression of IGF2BP3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	tissue samples with high or low expression of IGF2BP3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	tissue samples with high or low expression of IGF2BP3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq	tissue samples with high or low expression of IGF2BP3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
	Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of IGF2BP3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
	BioGPS Cell Line Gene Expression Profiles	cell lines with high or low expression of IGF2BP3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
	BioGPS Human Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of IGF2BP3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of IGF2BP3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	small molecule perturbations changing expression of IGF2BP3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
	CCLE Cell Line Gene CNV Profiles	cell lines with high or low copy number of IGF2BP3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
	CCLE Cell Line Gene Expression Profiles	cell lines with high or low expression of IGF2BP3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
	CCLE Cell Line Proteomics	Cell lines associated with IGF2BP3 protein from the CCLE Cell Line Proteomics dataset.
	CellMarker Gene-Cell Type Associations	cell types associated with IGF2BP3 gene from the CellMarker Gene-Cell Type Associations dataset.
	ChEA Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of IGF2BP3 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
	ChEA Transcription Factor Targets	transcription factors binding the promoter of IGF2BP3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
	ChEA Transcription Factor Targets 2022	transcription factors binding the promoter of IGF2BP3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
	CMAP Signatures of Differentially Expressed Genes for Small Molecules	small molecule perturbations changing expression of IGF2BP3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores	cellular components containing IGF2BP3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores 2025	cellular components containing IGF2BP3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Experimental Protein Localization Evidence Scores	cellular components containing IGF2BP3 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
	COMPARTMENTS Experimental Protein Localization Evidence Scores 2025	cellular components containing IGF2BP3 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores	cellular components co-occuring with IGF2BP3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	cellular components co-occuring with IGF2BP3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
	CORUM Protein Complexes	protein complexs containing IGF2BP3 protein from the CORUM Protein Complexes dataset.
	COSMIC Cell Line Gene CNV Profiles	cell lines with high or low copy number of IGF2BP3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
	COSMIC Cell Line Gene Mutation Profiles	cell lines with IGF2BP3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
	CTD Gene-Chemical Interactions	chemicals interacting with IGF2BP3 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
	CTD Gene-Disease Associations	diseases associated with IGF2BP3 gene/protein from the curated CTD Gene-Disease Associations dataset.
	DepMap CRISPR Gene Dependency	cell lines with fitness changed by IGF2BP3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
	DISEASES Experimental Gene-Disease Association Evidence Scores	diseases associated with IGF2BP3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Experimental Gene-Disease Association Evidence Scores 2025	diseases associated with IGF2BP3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores	diseases co-occuring with IGF2BP3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	diseases co-occuring with IGF2BP3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
	DisGeNET Gene-Disease Associations	diseases associated with IGF2BP3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
	DisGeNET Gene-Phenotype Associations	phenotypes associated with IGF2BP3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
	ENCODE Histone Modification Site Profiles	histone modification site profiles with high histone modification abundance at IGF2BP3 gene from the ENCODE Histone Modification Site Profiles dataset.
	ENCODE Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of IGF2BP3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
	ENCODE Transcription Factor Targets	transcription factors binding the promoter of IGF2BP3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	PubMedIDs of publications reporting gene signatures containing IGF2BP3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.